Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

  • Read more about A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

Validation of Prognostic Clinical Risk Scores in Predicting Outcome for Patients With COVID-19 at Initial Triage

  • Read more about Validation of Prognostic Clinical Risk Scores in Predicting Outcome for Patients With COVID-19 at Initial Triage

Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

  • Read more about Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

Diaphragm Dysfunction After COVID-19 as Determined by Dynamic Chest Radiography

  • Read more about Diaphragm Dysfunction After COVID-19 as Determined by Dynamic Chest Radiography

A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

  • Read more about A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

Retrospective Study of Pediatric Patients With Covid-19 in Alsace in 2020-2021

  • Read more about Retrospective Study of Pediatric Patients With Covid-19 in Alsace in 2020-2021

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine (CHO Cell)LYB002V14 in Booster Vaccination

  • Read more about Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine (CHO Cell)LYB002V14 in Booster Vaccination

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

  • Read more about Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

  • Read more about Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients

  • Read more about Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 88
  • Page 89
  • Page 90
  • Page 91
  • Current page 92
  • Page 93
  • Page 94
  • Page 95
  • Page 96
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA